/C O R R E C T I O N -- Bridge to Life, Ltd./

Barchart · 1d ago

DULUTH, Ga, and LONDON, Aug. 27, 2026 /PRNewswire/ -- Bridge to Life™ Ltd., a global leader in organ preservation solutions and perfusion technologies, today highlighted the recent release of new HealthTech guidance by the United Kingdom's National Institute for Health and Care Excellence (NICE),  recommending routine National Health Service (NHS) funding for ex-situ machine perfusion devices, including Bridge to Life's VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, to preserve deceased donor livers for transplantation.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.